These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25747511)

  • 1. How profitable is a voluntary deductible in health insurance for the consumer?
    van Winssen KP; van Kleef RC; van de Ven WP
    Health Policy; 2015 May; 119(5):688-95. PubMed ID: 25747511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential determinants of deductible uptake in health insurance: How to increase uptake in The Netherlands?
    van Winssen KP; van Kleef RC; van de Ven WP
    Eur J Health Econ; 2016 Dec; 17(9):1059-1072. PubMed ID: 26613608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A voluntary deductible in health insurance: the more years you opt for it, the lower your premium?
    van Winssen KP; van Kleef RC; van de Ven WP
    Eur J Health Econ; 2017 Mar; 18(2):209-226. PubMed ID: 26857921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does risk equalization reduce the viability of voluntary deductibles?
    van Kleef RC; Beck K; van de Ven WP; van Vliet RC
    Int J Health Care Finance Econ; 2007 Mar; 7(1):43-58. PubMed ID: 17431767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deductibles in health insurance: can the actuarially fair premium reduction exceed the deductible?
    Bakker FM; van Vliet RC; van de Ven WP
    Health Policy; 2000 Sep; 53(2):123-41. PubMed ID: 10958993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk equalization and voluntary deductibles: a complex interaction.
    van Kleef RC; Beck K; van de Ven WP; van Vliet RC
    J Health Econ; 2008 Mar; 27(2):427-43. PubMed ID: 18178276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifted deductibles for high risks: more effective in reducing moral hazard than traditional deductibles.
    van Kleef RC; van de Ven WP; van Vliet RC
    J Health Econ; 2009 Jan; 28(1):198-209. PubMed ID: 18996607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is a Refundable Deductible Insurance an advantage for the insured? a mathematical approach.
    Claramunt MM; Mármol M
    PLoS One; 2021; 16(2):e0247030. PubMed ID: 33596261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimum generosity levels in a competitive health insurance market.
    Remmerswaal M; Boone J; Douven R
    J Health Econ; 2023 Jul; 90():102782. PubMed ID: 37392721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The introduction of deductibles for prescription drugs in a national health insurance: compulsory or voluntary?
    Bakker FM; van Vliet RC
    Health Policy; 1995 Jan; 31(1):53-65. PubMed ID: 10140363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Among Low-Income Respondents With Diabetes, High-Deductible Versus No-Deductible Insurance Sharply Reduces Medical Service Use.
    Rabin DL; Jetty A; Petterson S; Saqr Z; Froehlich A
    Diabetes Care; 2017 Feb; 40(2):239-245. PubMed ID: 27956384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moral hazard and selection for voluntary deductibles.
    Alessie RJM; Angelini V; Mierau JO; Viluma L
    Health Econ; 2020 Oct; 29(10):1251-1269. PubMed ID: 32734647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection on Moral Hazard in Health Insurance.
    Einav L; Finkelstein A; Ryan S; Schrimpf P; Cullen MR
    Am Econ Rev; 2013 Feb; 103(1):178-219. PubMed ID: 24748682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to Survive a High-Deductible Health Plan. Is your insurance giving you a bad case of sticker shock? Here are ways to ease the pain.
    Rosato D
    Consum Rep; 2017 Jan; 82(1):16-20. PubMed ID: 27987531
    [No Abstract]   [Full Text] [Related]  

  • 15. Can premium differentiation counteract adverse selection in the Dutch supplementary health insurance? A simulation study.
    van Winssen KPM; van Kleef RC; van de Ven WPMM
    Eur J Health Econ; 2018 Jun; 19(5):757-768. PubMed ID: 28762051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deductibles and health care expenditures: empirical estimates of price sensitivity based on administrative data.
    van Vliet RC
    Int J Health Care Finance Econ; 2004 Dec; 4(4):283-305. PubMed ID: 15467406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Deductible Health Plans and Healthcare Access, Use, and Financial Strain in Those with Chronic Obstructive Pulmonary Disease.
    Gaffney A; White A; Hawks L; Himmelstein D; Woolhandler S; Christiani DC; McCormick D
    Ann Am Thorac Soc; 2020 Jan; 17(1):49-56. PubMed ID: 31599647
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of reinsuring a deductible on pharmaceutical spending: A Dutch case study on low-income people.
    Non M; van Kleef R; van der Galiën O; Douven R
    Health Policy; 2019 Oct; 123(10):976-981. PubMed ID: 31378537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential premium range of risk-rating in competitive markets for supplementary health insurance.
    Paolucci F; Prinsze F; Stam PJ; van de Ven WP
    Int J Health Care Finance Econ; 2009 Sep; 9(3):243-58. PubMed ID: 19125326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans.
    Leopold C; Wagner AK; Zhang F; Lu CY; Earle CC; Nekhlyudov L; Ross-Degnan D; Wharam JF
    Breast Cancer Res Treat; 2018 Sep; 171(2):449-459. PubMed ID: 29855813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.